DE69127346D1 - Behandlung thrombotischer ereignisse - Google Patents

Behandlung thrombotischer ereignisse

Info

Publication number
DE69127346D1
DE69127346D1 DE69127346T DE69127346T DE69127346D1 DE 69127346 D1 DE69127346 D1 DE 69127346D1 DE 69127346 T DE69127346 T DE 69127346T DE 69127346 T DE69127346 T DE 69127346T DE 69127346 D1 DE69127346 D1 DE 69127346D1
Authority
DE
Germany
Prior art keywords
treatment
thrombotic events
platelet aggregates
amount
hementin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69127346T
Other languages
English (en)
Other versions
DE69127346T2 (de
Inventor
Roy T Sawyer
Christopher Powell-Jones
Anthony Atkinson
Asgar Electricwala
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909007879A external-priority patent/GB9007879D0/en
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Application granted granted Critical
Publication of DE69127346D1 publication Critical patent/DE69127346D1/de
Publication of DE69127346T2 publication Critical patent/DE69127346T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69127346T 1990-04-06 1991-04-08 Behandlung thrombotischer ereignisse Expired - Lifetime DE69127346T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909007879A GB9007879D0 (en) 1990-04-06 1990-04-06 Treatment of thrombotic events
GB909008863A GB9008863D0 (en) 1990-04-06 1990-04-20 Treatment of thrombotic events
PCT/GB1991/000549 WO1991015576A1 (en) 1990-04-06 1991-04-08 Treatment of thrombotic events

Publications (2)

Publication Number Publication Date
DE69127346D1 true DE69127346D1 (de) 1997-09-25
DE69127346T2 DE69127346T2 (de) 1998-02-26

Family

ID=26296911

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69127346T Expired - Lifetime DE69127346T2 (de) 1990-04-06 1991-04-08 Behandlung thrombotischer ereignisse

Country Status (10)

Country Link
EP (1) EP0487660B1 (de)
JP (1) JP3878668B2 (de)
AT (1) ATE157121T1 (de)
AU (1) AU645804B2 (de)
CA (1) CA2058635C (de)
DE (1) DE69127346T2 (de)
DK (1) DK0487660T3 (de)
ES (1) ES2107460T3 (de)
GR (1) GR3025238T3 (de)
WO (1) WO1991015576A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9309509D0 (en) * 1993-05-07 1993-06-23 Merck Patent Gmbh Thrombin inhibitors
CA2623565A1 (en) 2005-09-28 2007-04-05 Biovascular, Inc. Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation
EP2316465A1 (de) * 2009-10-15 2011-05-04 Centre National De La Recherche Scientifique Verwendung von Extrakt von Blutegelspeichel als antibakterielles Mittel zur Herstellung unterschiedlicher Zusammensetzungen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390630A (en) * 1980-10-28 1983-06-28 The Regents Of The University Of California Hementin--a fibrinolytic agent
GB8808810D0 (en) * 1988-04-14 1988-05-18 Biopharm Clinical Research Ltd Heparin-containing formulations

Also Published As

Publication number Publication date
ES2107460T3 (es) 1997-12-01
JP3878668B2 (ja) 2007-02-07
DK0487660T3 (da) 1998-03-30
AU7690191A (en) 1991-10-30
DE69127346T2 (de) 1998-02-26
AU645804B2 (en) 1994-01-27
WO1991015576A1 (en) 1991-10-17
JPH05500906A (ja) 1993-02-25
CA2058635A1 (en) 1991-10-07
GR3025238T3 (en) 1998-02-27
CA2058635C (en) 2002-02-05
ATE157121T1 (de) 1997-09-15
EP0487660B1 (de) 1997-08-20
EP0487660A1 (de) 1992-06-03

Similar Documents

Publication Publication Date Title
FI925296A0 (fi) Polypeptider av en fibrinbindande domaen, anvaendning och foerfaranden foer framstaellning av desamma
DE68918155T2 (de) Chirurgisches Klebstoffmaterial.
DE69002395D1 (de) N-terminale fragmente von menschliches serumalbumin enthaltenden fusionsproteinen.
ATE171042T1 (de) Verfahren und zusammensetzungen zur verbesserung der symptome von sepsis
DE69229272T2 (de) Topischer fibrinogenkomplex
ES2086301T3 (es) Inhibicion de una oclusion trombotica arterial o tromboembolismo.
FI962483A (fi) Menetelmät ja materiaalit Staphylococcus aureusin detektoimiseksi
DE69410254D1 (de) Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente
ATA29495A (de) Zusammensetzung und verfahren zur prävention und behandlung von entzündungen mit immunglobulin a
ES2183805T3 (es) Procedimiento de preparacion de un medicamento trombolitico.
DK0858504T3 (da) Diagnostiske midler mod og behandlinger af periodontale sygdomme
ATE330943T1 (de) Herstellungsverfahren von huperzine a und deren analogen und verbindungen nützlich dazu
BR9406292A (pt) Complexo de inclusão de taxol ou taxotere ou extrato de taxus formados com ciclodextrinas sua preparação e uso
ATE157011T1 (de) Verabreichung von mitteln
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
DE69110713D1 (de) 7-Oxabicycloheptan-imidazol-prostaglandin-Analoge, verwendbar bei der Behandlung von thrombotischen und vasospastischen Erkrankungen.
FR2601679B1 (fr) Immunotoxines, procede de preparation et compositions pharmaceutiques en contenant
DE69127346D1 (de) Behandlung thrombotischer ereignisse
ATE11224T1 (de) Wundheilende zusammensetzungen.
DE69705110T2 (de) Topische pharmazeutische zusammensetzungen, welche heparin enthalten
DE69534601D1 (de) Gebrauch von antikörpern zur verhinderung von auswirkungen hervorgerufen durch grampositive- und myko-bakterien
FR2646603B1 (fr) Composition nettoyante
ES2106183T3 (es) Suero antiveneno.
DK0517756T3 (da) Vævs-plasminogenaktivator med fibrinspecifikke egenskaber
DE69112747D1 (de) Inhibitoren der Calciumaufnahme.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition